We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A purple brain.
Product News

Evotec Announces Progress in Neuroscience Collaboration With Bristol Myers Squibb

Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research.
A lab worker holding a rack of centrifuge tubes.
Product News

Neurolentech Signs Technology Access Partnership With Kaerus Bioscience To Advance Neurodevelopmental Disorder Research

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes.
A scientist with an assay plate.
Product News

Aptamer and Neuro-Bio Enter the Second Phase of Alzheimer’s Test Development

Aptamer Group plc announces the second phase of its on-going partnership with Neuro-Bio to develop Optimer binders for a lateral flow test for the early diagnosis of Alzheimer’s disease.
Cells under a microscope.
Product News

Novel Reagents Advance Research Into Parkinsons Disease and Sleep Disorders

AMSBIO describe how life science research groups are using their BioPORTER®, Detachin™, and SoluLyse™ reagents to make groundbreaking advances in Parkinson’s research, hypersomnia studies and eco-friendly microbial ester production.
Brain scans.
Product News

PharmaKure and Universiti Teknologi MARA (UiTM) Announce Partnership To Advance Research

Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s Disease.
A scientist holding up a 96-well plate.
Product News

PharmaKure Announces Study Success for Novel Blood Test To Identify Biomarkers in Patients With Alzheimer’s Disease

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease.
Nerve cells.
Product News

Cellectricon Expands Neuroscience Contract Research Portfolio With New Neuroplasticity Services

Newly-launched module set to accelerate drug discovery in therapeutic areas such as neuropsychiatry, epilepsy and neurodegeneration.
A scientist holding up a glass vial.
Product News

New Report Reveals Challenges and Opportunities in Life Science R&D Experiments

Synthace has released a comprehensive analyst report that sheds light on the industry challenges faced by researchers and highlights opportunities for improvement.
Human cells.
Product News

Exploring Neurodegenerative Diseases in Microgravity

AMSBIO, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM).
A man and a woman stand next to the Neuro-Bio and Aptamer Group logos.
Product News

Aptamer Group and Neuro-Bio Partner To Develop an Alzheimer’s Disease Diagnostic Test

Aptamer Group plc and Neuro-Bio announce success in the development of Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer’s disease.
Advertisement